Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Gitelman syndrome (GS) is an autosomal recessive disorder characterized by hypokalemic metabolic alkalosis in conjunction with significant hypomagnesemia and hypocalciuria. The GS phenotype is caused by mutations in the solute carrier family 12, member 3 (SLC12A3) gene that encodes the thiazide-sensitive NaCl cotransporter (NCC). We analyzed DNA samples of 163 patients with a clinical suspicion of GS by direct sequencing of all 26 exons of the SLC12A3 gene. In total, 114 different mutations were identified, 31 of which have not been reported before. These novel variants include 3 deletions, 18 missense, 6 splice site and 4 nonsense mutations. We selected seven missense mutations to investigate their effect on NCC activity and plasma membrane localization by using the Xenopus laevis oocyte expression system. The Thr392Ile mutant did not display transport activity (probably class 2 mutation), while the Asn442Ser and Gln1030Arg NCC mutants showed decreased plasma membrane localization and consequently function, likely due to impaired trafficking (class 3 mutation). Even though the NaCl uptake was hampered for NCC mutants Glu121Asp, Pro751Leu, Ser475Cys and Tyr489His, the transporters reached the plasma membrane (class 4 mutation), suggesting an effect on NCC regulation or ion affinity. The present study shows the identification of 38 novel mutations in the SLC12A3 gene and provides insight into the mechanisms that regulate NCC.
Brown,
Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.
1996, Pubmed
Brown,
Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.
1996,
Pubmed Calò,
Hypomagnesemia and chondrocalcinosis in Bartter's and Gitelman's syndrome: review of the pathogenetic mechanisms.
2000,
Pubmed Chobanian,
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
2003,
Pubmed Colussi,
A thiazide test for the diagnosis of renal tubular hypokalemic disorders.
2007,
Pubmed Cruz,
Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life.
2001,
Pubmed Cuppen,
The zyxin-related protein TRIP6 interacts with PDZ motifs in the adaptor protein RIL and the protein tyrosine phosphatase PTP-BL.
2000,
Pubmed De Jong,
Functional expression of mutations in the human NaCl cotransporter: evidence for impaired routing mechanisms in Gitelman's syndrome.
2002,
Pubmed
,
Xenbase Ellison,
Thiazide-sensitive sodium chloride cotransport in early distal tubule.
1987,
Pubmed Frischmeyer,
Nonsense-mediated mRNA decay in health and disease.
1999,
Pubmed Gamba,
Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporter.
1993,
Pubmed
,
Xenbase Gamba,
Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters.
2005,
Pubmed Gamba,
Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney.
1994,
Pubmed
,
Xenbase Gitelman,
A new familial disorder characterized by hypokalemia and hypomagnesemia.
1966,
Pubmed Hisakawa,
A case of Gitelman's syndrome with chondrocalcinosis.
1998,
Pubmed Hoover,
N-Glycosylation at two sites critically alters thiazide binding and activity of the rat thiazide-sensitive Na(+):Cl(-) cotransporter.
2003,
Pubmed
,
Xenbase Koolen,
Screening for subtelomeric rearrangements in 210 patients with unexplained mental retardation using multiplex ligation dependent probe amplification (MLPA).
2004,
Pubmed Kunchaparty,
Defective processing and expression of thiazide-sensitive Na-Cl cotransporter as a cause of Gitelman's syndrome.
1999,
Pubmed
,
Xenbase Lemmink,
Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain.
1998,
Pubmed Mastroianni,
Novel molecular variants of the Na-Cl cotransporter gene are responsible for Gitelman syndrome.
1996,
Pubmed Melander,
Genetic variants of thiazide-sensitive NaCl-cotransporter in Gitelman's syndrome and primary hypertension.
2000,
Pubmed Moreno,
Affinity-defining domains in the Na-Cl cotransporter: a different location for Cl- and thiazide binding.
2006,
Pubmed
,
Xenbase Pacheco-Alvarez,
The Na+:Cl- cotransporter is activated and phosphorylated at the amino-terminal domain upon intracellular chloride depletion.
2006,
Pubmed
,
Xenbase Plotkin,
Localization of the thiazide sensitive Na-Cl cotransporter, rTSC1 in the rat kidney.
1996,
Pubmed Riveira-Munoz,
Gitelman's syndrome: towards genotype-phenotype correlations?
2007,
Pubmed Robben,
Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus.
2007,
Pubmed Sabath,
Pathophysiology of functional mutations of the thiazide-sensitive Na-Cl cotransporter in Gitelman disease.
2004,
Pubmed
,
Xenbase Shao,
A novel SLC12A3 splicing mutation skipping of two exons and preliminary screening for alternative splice variants in human kidney.
2008,
Pubmed Simon,
Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter.
1996,
Pubmed Simon,
The molecular basis of inherited hypokalemic alkalosis: Bartter's and Gitelman's syndromes.
1996,
Pubmed Spencer,
Familial hypokalaemia and hypomagnesaemia. A further family.
1976,
Pubmed Syrén,
Identification of fifteen novel mutations in the SLC12A3 gene encoding the Na-Cl Co-transporter in Italian patients with Gitelman syndrome.
2002,
Pubmed Vargas-Poussou,
Spectrum of mutations in Gitelman syndrome.
2011,
Pubmed
